- Home
- INBK vs ALDX Comparison
INBK vs ALDX Comparison
Compare INBK & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- ALDX
- Stock Information
- Founded
- INBK 1999
- ALDX 2004
- Country
- INBK United States
- ALDX United States
- Employees
- INBK N/A
- ALDX N/A
- Industry
- INBK Major Banks
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- ALDX Health Care
- Exchange
- INBK Nasdaq
- ALDX Nasdaq
- Market Cap
- INBK 196.2M
- ALDX 160.8M
- IPO Year
- INBK N/A
- ALDX 2014
- Fundamental
- Price
- INBK $23.32
- ALDX $3.05
- Analyst Decision
- INBK Buy
- ALDX Strong Buy
- Analyst Count
- INBK 4
- ALDX 2
- Target Price
- INBK $34.50
- ALDX $9.50
- AVG Volume (30 Days)
- INBK 37.3K
- ALDX 792.5K
- Earning Date
- INBK 07-23-2025
- ALDX 07-31-2025
- Dividend Yield
- INBK 1.03%
- ALDX N/A
- EPS Growth
- INBK 27.37
- ALDX N/A
- EPS
- INBK 2.40
- ALDX N/A
- Revenue
- INBK $114,609,000.00
- ALDX N/A
- Revenue This Year
- INBK $5.36
- ALDX N/A
- Revenue Next Year
- INBK $17.09
- ALDX N/A
- P/E Ratio
- INBK $9.72
- ALDX N/A
- Revenue Growth
- INBK 20.13
- ALDX N/A
- 52 Week Low
- INBK $19.54
- ALDX $1.14
- 52 Week High
- INBK $43.27
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- INBK 46.70
- ALDX 61.89
- Support Level
- INBK $22.46
- ALDX $2.60
- Resistance Level
- INBK $24.67
- ALDX $3.24
- Average True Range (ATR)
- INBK 0.67
- ALDX 0.22
- MACD
- INBK -0.05
- ALDX 0.09
- Stochastic Oscillator
- INBK 38.91
- ALDX 80.93
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.